Literature DB >> 12794130

Ephrin-A1 induces c-Cbl phosphorylation and EphA receptor down-regulation in T cells.

Nigel Sharfe1, Andrew Freywald, Ana Toro, Chaim M Roifman.   

Abstract

Eph receptor tyrosine kinases are expressed by T lineage cells, and stimulation with their ligands, the ephrins, has recently been shown to modulate T cell behavior. We show that ephrin-A1 stimulation of Jurkat T cells induces tyrosine phosphorylation of EphA3 receptors and cytoplasmic proteins, including the c-cbl proto-oncogene. Cbl phosphorylation was also observed in peripheral blood T cells. In contrast, stimulation of Jurkat cells with the EphB receptor ligand ephrin-B1 does not cause Cbl phosphorylation. EphA activation also induced Cbl association with Crk-L and Crk-II adapters, but not the related Grb2 protein. Induction of Cbl phosphorylation upon EphA activation appeared to be dependent upon Src family kinase activity, as Cbl phosphorylation was selectively abrogated by the Src family inhibitor 4-amino-5(4-chlorophenyl-7-(tert-butyl)pyrazolo[3,4-d]pyrimidine, while EphA phosphorylation was unimpaired. Ephrin-A1 stimulation of Jurkat cells was also found to cause down-regulation of endogenous EphA3 receptors from the cell surface and their degradation. In accordance with the role of Cbl as a negative regulator of receptor tyrosine kinases, overexpression of wild-type Cbl, but not its 70-Z mutant, was found to down-regulate EphA receptor expression. Receptor down-regulation could also be inhibited by blockage of Src family kinase activity. Our findings show that EphA receptors can actively signal in T cells, and that Cbl performs multiple roles in this signaling pathway, functioning to transduce signals from the receptors as well as regulating activated EphA receptor expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794130     DOI: 10.4049/jimmunol.170.12.6024

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  EphB6-null mutation results in compromised T cell function.

Authors:  Hongyu Luo; Guang Yu; Johanne Tremblay; Jiangping Wu
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

2.  EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

Authors:  Thao M Nguyen; Agnes Arthur; John D Hayball; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2013-06-29       Impact factor: 3.272

3.  EphA2 signaling following endocytosis: role of Tiam1.

Authors:  Pomme Boissier; Jin Chen; Uyen Huynh-Do
Journal:  Traffic       Date:  2013-10-10       Impact factor: 6.215

Review 4.  Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.

Authors:  Erika Gucciardo; Nami Sugiyama; Kaisa Lehti
Journal:  Cell Mol Life Sci       Date:  2014-05-04       Impact factor: 9.261

5.  Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.

Authors:  Hea Nam Hong; You Jin Won; Ju Hee Shim; Hyun Ji Kim; Seung Hee Han; Byung Sik Kim; Hee Sung Kim
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-12       Impact factor: 4.553

Review 6.  Eph/ephrin signaling in epidermal differentiation and disease.

Authors:  Samantha Lin; Bingcheng Wang; Spiro Getsios
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

7.  Identification of the soluble EphA7-interacting protein Nicalin as a regulator of EphA7 expression.

Authors:  Xiaolei Wang; Zhaobao Wang
Journal:  Mol Cell Biochem       Date:  2020-09-10       Impact factor: 3.396

8.  EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation.

Authors:  Seth S Margolis; John Salogiannis; David M Lipton; Caleigh Mandel-Brehm; Zachary P Wills; Alan R Mardinly; Linda Hu; Paul L Greer; Jay B Bikoff; Hsin-Yi Henry Ho; Michael J Soskis; Mustafa Sahin; Michael E Greenberg
Journal:  Cell       Date:  2010-10-29       Impact factor: 41.582

9.  The SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptors.

Authors:  Jieun Kim; Haeryung Lee; Yujin Kim; Sooyeon Yoo; Eunjeong Park; Soochul Park
Journal:  Mol Cell Biol       Date:  2010-01-25       Impact factor: 4.272

10.  Ubiquitination switches EphA2 vesicular traffic from a continuous safeguard to a finite signalling mode.

Authors:  Ola Sabet; Rabea Stockert; Georgia Xouri; Yannick Brüggemann; Angel Stanoev; Philippe I H Bastiaens
Journal:  Nat Commun       Date:  2015-08-21       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.